Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Dermatologic 1Classical hematology 1Breast 1

Conditions

Thrombocytopenia 1Neoplasms 1Hemostatic Disorders 1

Interventions

Cyclophosphamide 17fludarabine phosphate 14Whole-Body Irradiation 11Mycophenolic Acid 9Epoetin Alfa 9Cyclosporine 9Busulfan 9fludarabine 8Cord Blood Stem Cell Transplantation 8Antilymphocyte Serum 8Filgrastim 6Tacrolimus 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Methotrexate 5Darbepoetin alfa 5Dalteparin 5Cytarabine 5eltrombopag 4Tinzaparin 4Thiotepa 4Platelet Transfusion 4Melphalan 4Etoposide 4Arsenic Trioxide 4thymoglobulin 3epoetin beta 3Vorinostat 3Transplantation 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tranexamic Acid × Classical hematology × Clear all
NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

University of Pittsburgh

Phase 1/2 Terminated
11 enrolled 15 charts
Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡